pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 607 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    AGuIX
    Glioblastoma Multiforme (GBM) NH TherAguix SAS
  • Phase 2
    AI-081
    Solid Tumor OncoC4 Inc
  • Phase 2
    ALEP-02
    Cervical Cancer Alentis Therapeutics AG
  • Phase 2
← prev
page 2 of 21
next →
131
Pain89
Neurology1
ALG.APV-527
Cervical Cancer
Alligator Bioscience AB
  • Phase 2
    AMB-051
    Tenosynovial Giant Cell Tumor AmMax Bio Inc
  • Phase 2
    ANS-01
    Non-Small Cell Lung Cancer Avistone Biotechnology Co Ltd
  • Phase 2
    ANV-419
    Metastatic Melanoma Anaveon AG
  • Phase 2
    ANV-600
    Melanoma Anaveon AG
  • Phase 2
    AP-030
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Apollo Therapeutics Ltd
  • Phase 2
    APG-157
    Squamous Cell Carcinoma Aveta Biomics Inc
  • Phase 2
    APL-2302
    Breast Cancer Asieris Pharmaceuticals (USA) Inc
  • Phase 2
    APS-03118
    Medullary Thyroid Cancer Applied Pharmaceutical Science Inc
  • Phase 2
    APTA-16
    Myelodysplastic Syndrome (Preleukemia) AptaBio Therapeutics Inc
  • Phase 2
    ARD-103
    Refractory Acute Myeloid Leukemia ARCE Therapeutics Inc
  • Phase 2
    ART-6043
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Artios Pharma Ltd
  • Phase 2
    ARTS-021
    Endometrial Cancer Avenzo Therapeutics Inc
  • Phase 2
    ARTS-023
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Avenzo Therapeutics Inc
  • Phase 2
    ARV-806
    Colorectal Cancer$ARVN ARVINAS, INC.
  • Phase 2
    ATRN-119
    Ovarian Cancer$APRE Aprea Therapeutics, Inc.
  • Phase 2
    ATX-295
    Ovarian Cancer Accent Therapeutics Inc
  • Phase 2
    AUTO-3
    B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla…$AUTL Autolus Therapeutics plc
  • Phase 2
    AVC-203
    Diffuse Large B-Cell Lymphoma AvenCell Therapeutics Inc
  • Phase 2
    AVGBM-1
    Glioblastoma Multiforme (GBM) AiVita Biomedical Inc
  • Phase 2
    AZD-0120
    Refractory Multiple Myeloma Gracell Biotechnologies Inc
  • Phase 2
    AZD-5863
    Adenocarcinoma Of The Gastroesophageal Junction$AZN ASTRAZENECA PLC
  • Phase 2
    Activated T Lymphocytes
    Hepatocellular Carcinoma Lukas Biomedical Inc
  • Phase 2
    AdAPT-001
    Chondrosarcoma EpicentRx Inc
  • Phase 2
    BAT-8006
    Epithelial Ovarian Cancer Bio-Thera Solutions Ltd
  • Phase 2
    BB-1701
    Human Epidermal Growth Factor Receptor 2 Positive Breast… Bliss Biopharmaceutical (Hangzhou) Co Ltd
  • Phase 2
    BBT-207
    Non-Small Cell Lung Cancer Parataxis Korea Inc